Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
---|---|---|---|---|
Income Statement | - | |||
Total Revenue | - | - | - | - |
Gross Profit | - | - | - | - |
EBIT | - | - | - | - |
EBITDA | - | - | - | - |
Net Income Common Stockholders | - | - | - | - |
Balance Sheet | - | |||
Cash, Cash Equivalents and Short-Term Investments | $ 83.57M | $ 82.26M | $ 235.50M | $ 82.12M |
Total Assets | $ 825.69M | $ 718.45M | $ 708.39M | $ 653.91M |
Total Debt | $ 440.97M | $ 368.36M | $ 382.88M | $ 312.86M |
Net Debt | $ 357.40M | $ 286.10M | $ 147.37M | $ 230.75M |
Total Liabilities | $ 573.30M | $ 484.88M | $ 485.34M | $ 427.54M |
Stockholders Equity | $ 252.40M | $ 233.57M | $ 223.06M | $ 226.37M |
Cash Flow | - | |||
Free Cash Flow | - | - | - | - |
Operating Cash Flow | - | - | - | - |
Investing Cash Flow | - | - | - | - |
Financing Cash Flow | - | - | - | - |